NEW YORK (GenomeWeb) – Exact Sciences reported on Sunday that it expects fourth quarter revenues of $34.9 million to $35.4 million, and FY 2016 revenues of $99.0 million to $99.5 million.

The firm's preliminary revenues soundly beat the average Wall Street estimate of $30.2 million for Q4 and $94.2 million for 2016.